These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22180674)

  • 1. Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.
    Smith JP
    Yale J Biol Med; 2011 Dec; 84(4):361-9. PubMed ID: 22180674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarrier-based interventions for the management of MDR/XDR-TB.
    Mustafa S; Pai RS; Singh G; Kusum Devi V
    J Drug Target; 2015 May; 23(4):287-304. PubMed ID: 25766078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis.
    Garg T; Rath G; Murthy RR; Gupta UD; Vatsala PG; Goyal AK
    Curr Pharm Des; 2015; 21(22):3076-89. PubMed ID: 26027577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments.
    Suman SK; Chandrasekaran N; Priya Doss CG
    Clin Microbiol Rev; 2023 Dec; 36(4):e0008823. PubMed ID: 38032192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious disease. Drug-resistant TB on the rise.
    Stokstad E
    Science; 2000 Mar; 287(5462):2391. PubMed ID: 10766610
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Management of Drug-resistant Mycobacterium tuberculosis Strains: Pathogen-targeted Versus Host-directed Treatment Approaches.
    Al-Ghafli H; Al-Hajoj S
    Curr Pharm Biotechnol; 2019; 20(4):272-284. PubMed ID: 30062961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates on drug resistance in Mycobacterium tuberculosis.
    Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
    J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in chemotherapy of multidrug-resistant and rifampicin-resistant tuberculosis].
    Liu SS; Wang LZ; Tang SJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):371-375. PubMed ID: 32294820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
    Singh J; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study.
    Yunusbaeva M; Borodina L; Alekseev P; Davydov R; Yunusbaev U; Sharipov R; Bilalov F; Yunusbayev B
    Int J Infect Dis; 2019 Apr; 81():203-209. PubMed ID: 30794942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.
    Palomino JC; Martin A
    Future Microbiol; 2016; 11(4):539-47. PubMed ID: 27070731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant and multidrug-resistant tubercle bacilli.
    Petrini B; Hoffner S
    Int J Antimicrob Agents; 1999 Oct; 13(2):93-7. PubMed ID: 10595567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic drug-resistant tuberculosis].
    Greinert U; Hillemann D; Lange C; Richter E
    Med Klin (Munich); 2007 Dec; 102(12):957-66. PubMed ID: 18075716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates.
    Horita Y; Takii T; Yagi T; Ogawa K; Fujiwara N; Inagaki E; Kremer L; Sato Y; Kuroishi R; Lee Y; Makino T; Mizukami H; Hasegawa T; Yamamoto R; Onozaki K
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4140-5. PubMed ID: 22615274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of resistance in multi drug resistant tuberculosis patients.
    Irfan S; Hassan Q; Hasan R
    J Pak Med Assoc; 2006 Sep; 56(9):397-400. PubMed ID: 17091751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities.
    Patil K; Bagade S; Bonde S; Sharma S; Saraogi G
    Biomed Pharmacother; 2018 Mar; 99():735-745. PubMed ID: 29710471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.
    Müller B; Borrell S; Rose G; Gagneux S
    Trends Genet; 2013 Mar; 29(3):160-9. PubMed ID: 23245857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment options for multidrug-resistant tuberculosis.
    Field SK; Fisher D; Jarand JM; Cowie RL
    Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.